Daemyung Chemical Increases Pledged Shares via Contract Amendment for LOGEN, Raising Financial Risk for Largest Shareholder
Daemyung Chemical amended its stock pledge contracts for LOGEN by extending maturities and adding collateral, increasing pledged shares by 113,730 to a total of 29,173,295 shares, representing 51.95% of total outstanding shares.
This change does not raise new capital, but the high pledge ratio exposes the largest shareholder to margin call risk and potential forced liquidation if the stock price declines.
Counterparties include major Korean financial institutions such as Korea Securities Finance, KB Securities, and Hana Bank, which are credible, but total borrowings amount to approximately KRW 66 billion, indicating significant financial leverage.
[AI Summary]This pledge amendment by Daemyung Chemical is merely an extension of existing loans with minor additional collateral, resulting in no new capital inflow or equity dilution. However, with over half of outstanding shares already pledged, the risk of margin calls remains elevated, potentially undermining management stability.